Echo Therapeutics, Inc. (ECTE.OB) Completes Development of New Transdermal Drug Delivery System
Echo Therapeutics, Inc., developer of innovative healthcare products like the wireless, non-invasive, Symphony™ transdermal continuous glucose monitoring (tCGM) system for diabetics, and the transdermal, drug delivery, Prelude™ SkinPrep System, announced completion of product development on the Prelude system today, saying that the system was commercially ready for final clinical trials. The Company indicated no additional changes were required and that the current device would be identical to the one marketed after FDA approval. The Prelude system will be tested using LMX4 lidocaine cream and success will result in a 510-k filing with Ferndale Pharma Group for augmented delivery of the…